[The behavior of the sulfobromophthalein chromoelimination curves  subjects with ethylic hepatopathy treated with a liver extract enriched with nucleosides of the pyrimidine series and ith cyanocobalamine].
D000437:Alcoholism / Q000150:complications; D006801:Humans; D008107:Liver Diseases / Q000188:drug therapy* / Q000503:physiopathology; D008110:Liver Extracts / Q000627:therapeutic use*; D008111:Liver Function Tests; D009705:Nucleosides / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*; D013448:Sulfobromophthalein; D014805:Vitamin B 12 / Q000627:therapeutic use*
D008110:Liver Extracts; D009705:Nucleosides; D011743:Pyrimidines; D013448:Sulfobromophthalein; D014805:Vitamin B 12
Il comportamento delle curve di cromoeliminazione della bromosulfonftaleina in soggetti con epatopatia etilica trattati con un estratto epatico arricchito con nucleosidi della derie pirimidinica e con cianocobalamina.